Wolfgang Miesbach: Nurses at the Heart of Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Greta Mulders et al, published in Haemophilia Journal, adding։
“Nurses at the Heart of Gene Therapy, Gene therapy for haemophilia is changing everything – and this new open‑access paper makes one thing clear: without specialised nurses, it simply doesn’t work.
Mulders et al. show how haemophilia nurses are now:
- guiding shared decision‑making and translating complex risk/benefit discussions into real‑world choices
- coordinating eligibility work‑up, AAV testing, and site readiness before infusion
- running safe infusion days with close monitoring and clear protocols
- leading long‑term follow‑up across hub‑and‑spoke networks, including liver tests, factor levels, and steroid management
- supporting psychosocial adjustment and lifestyle change as patients move from chronic treatment to (near) normal life
- feeding data into registries and research so we can understand durability and safety in the real world
If we want gene therapy to deliver lasting, meaningful benefit for people with haemophilia, we must invest in haemophilia nursing – education, dedicated roles, and time for coordination and research.
Congratulations to Greta Mulders, Simon Fletcher, PhD, Aysen Tasgin, Marica Moro, Marlene Beijlevelt and Kate Khair”
Title: Defining the Role of Nurses in Gene Therapy for Haemophilia
Authors: Greta Mulders, Simon Fletcher, Aysen Tasgin, Marica Moro, Marléne Beijlevelt, Kate Khair
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 10:31Working Together for Better Outcomes in Hemophilia Care – Hemophilia Federation (India)
-
Oct 18, 2026, 08:02Neda Ashayeri: Global Perspectives on Hemophilia and Rare Bleeding Disorders in Abu Dhabi
-
Oct 18, 2026, 07:55Anu Thomas: A Stepwise Laboratory Approach to Positive IAT and Pretransfusion Compatibility
-
Oct 18, 2026, 07:49Matthew Hazell: Molecular Matching and the Future of Transfusion Practice
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure